Our Research Publications
Updated November 2023
Pagination
- Page 1
- Next page
Title | Authors | Year | Journal Sort descending | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
[Influence of Anticoagulants on Detection of ITP Platelet-Specific Autoantibodies and Relationship of Autoantibody Types with Glucocorticoid Efficacy] | Chen Y, Ge J, Ruan M, Zhu L-Y, Zeng Q-S, Xia R-X, Ni H | 2015 | Zhongguo shi yan xue ye xue za zhi | View [Influence of Anticoagulants on Detection of ITP Platelet-Specific Autoantibodies and Relationship of Autoantibody Types with Glucocorticoid Efficacy] | Researchers | Basic research |
Population pharmacokinetics of two recombinant human coagulation factor preparations in patients with hemophilia A | Hua BL, Chelle P, Yeung C, Gu J, Zhao YQ, Iorio A | 2019 | Zhonghua Xue Ye Xue Za Zhi | View Population pharmacokinetics of two recombinant human coagulation factor preparations in patients with hemophilia A | Researchers | Clinical research |
[Study on the relationship of platelet specific-autoantibodies with therapeutic outcomes by dexamethasone in immune thrombocytopenia purpura] | Chen Y, Ge J, Ruan M, Zhu L, Xie Y, Xia R, Ni H, Zeng Q | 2015 | Zhonghua Xue Ye Xue Za Zhi | View [Study on the relationship of platelet specific-autoantibodies with therapeutic outcomes by dexamethasone in immune thrombocytopenia purpura] | Researchers | Clinical research |
Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Alabdullatif M, Atreya CD, Ramirez-Arcos S | 2018 | Transfusion | View Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Researchers | New or improved product or process |
Improved in vitro quality of stored red blood cells upon oxygen reduction prior to riboflavin/UV light treatment of whole blood | Schubert P, Culibrk B, Chen D, Serrano K, Levin E, Chen Z, Zoescher P, Goodrich RP, Yoshida T, Devine DV | 2019 | Transfusion | View Improved in vitro quality of stored red blood cells upon oxygen reduction prior to riboflavin/UV light treatment of whole blood | Researchers | New or improved product or process |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype | Floch A, Vege S, Berardi P, Hannon J, Ochoa-Garay G, Lomas-Francis C, Westhoff CM | 2022 | Transfusion | View An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype | Researchers | Clinical research |
Database-driven research and big data analytic approaches in transfusion medicine | Ning S, Li N, Barty R, Arnold D, Heddle NM | 2022 | Transfusion | View Database-driven research and big data analytic approaches in transfusion medicine | Researchers | Clinical research |
Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units | Pasha R, Elmoazzen H, Pineault N | 2017 | Transfusion | View Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units | Researchers | New or improved product or process |
Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses | Heddle NM, Eikelboom J, Liu Y, Barty R, Cook RJ | 2015 | Transfusion | View Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses | Health care providers | Clinical research |
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation | Christou G, Kekre N, Petrcich W, Tokessy M, Neurath D, Giulivi A, Saidenberg E, McDiarmid S, Atkins H, Bence-Bruckler I, Bredeson C, Huebsch L, Sabloff M, Sheppard D, Tay J, Tinmouth A, Allan DS | 2015 | Transfusion | View Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation | Health care providers | Clinical research |
Lessons learned from Trypanosoma cruzi test implementation | Menitove JE, Leach-Bennett J, Sher G | 2012 | Transfusion | View Lessons learned from Trypanosoma cruzi test implementation | Blood operators | Other |
Resolving variable maternal D typing using serology and genotyping in selected prenatal patients | Clarke G, Hannon J, Berardi P, Barr G, Cote J, Fallis R, Alport T, Lane D, Petraszko T, Ochoa G, Goldman M | 2016 | Transfusion | View Resolving variable maternal D typing using serology and genotyping in selected prenatal patients | Health care providers | New or improved product or process |
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | MacIsaac J, Siddiqui R, Jamula E, Li N, Baker S, Webert KE, Evanovitch D, Heddle NM, Arnold DM | 2018 | Transfusion | View Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | Researchers | Clinical research |
Evaluation of immunohematology knowledge in hematology trainees | Yan M, Arsenault V, Pendergrast J | 2019 | Transfusion | View Evaluation of immunohematology knowledge in hematology trainees | Health care providers | Other |
Prevalence of Babesia in Canadian blood donors: June–October 2018 | Tonnetti L, O'Brien SF, Grégoire Y, Proctor MC, Drews SJ, Delage G, Fearon MA, Brès V, Linnen JM, Stramer SL | 2019 | Transfusion | View Prevalence of Babesia in Canadian blood donors: June–October 2018 | Researchers | Clinical research |
Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Schubert P, Johnson L, Culibrk B, Chen Z, Tan S, Marks DC, Devine DV | 2021 | Transfusion | View Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Researchers | New or improved product or process |
Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blake JT, McTaggart K, Couture C | 2021 | Transfusion | View Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blood operators | Benchmarking and standard setting |
2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium | Spitalnik SL, Triulzi D, Devine DV, Dzik WH, Eder AF, Gernsheimer T, Josephson CD, Kor DJ, Luban NLC, Roubinian NH, Mondoro T, Welniak LA, Zou S, Glynn S, for the State of the Science in Transfusion Medicine Working G | 2015 | Transfusion | View 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium | Other | Other |
A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing | Acker JP, Hansen AL, Kurach JD, Turner TR, Croteau I, Jenkins C | 2014 | Transfusion | View A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing | Blood operators | Benchmarking and standard setting |
Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop | Gallagher LM, Ganz PR, Yang H, Kessler DA, O'Brien SF, Custer BS, Busch MP, Dodd RY, Stramer SL, Walderhaug MO, Forshee RA, Williams AE, Epstein JS, Anderson SA | 2013 | Transfusion | View Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop | Blood operators | Other |
Changes in plasma unit distributions to hospitals over a 10-year period | Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH | 2018 | Transfusion | View Changes in plasma unit distributions to hospitals over a 10-year period | Blood operators | Clinical research |
Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates | Greco CA, Zhang JG, Kalab M, Yi Q-L, Ramirez-Arcos SM, Gyongyossy-Issa MIC | 2010 | Transfusion | View Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates | Researchers | Basic research |
Platelet concentrate functionality assessed by thromboelastography or rotational thromboelastometry | Arbaeen AF, Serrano K, Levin E, Devine DV | 2016 | Transfusion | View Platelet concentrate functionality assessed by thromboelastography or rotational thromboelastometry | Researchers | Basic research |
Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin | Leontyev D, Katsman Y, Ma XZ, Miescher S, Kasermann F, Branch DR | 2012 | Transfusion | View Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin | Researchers | Basic research |
The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based | Sandler SG, Eder AF, Goldman M, Winters JL | 2015 | Transfusion | View The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based | Health care providers | Clinical research |
Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Greco-Stewart V, Kiernan J, Killeen D, Haun S, Mercer D, Young K, Liwski RS, Allan DS | 2018 | Transfusion | View Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Health care providers | Clinical research |
Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Khadadah F, Callum J, Shelton D, Lin Y | 2018 | Transfusion | View Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization | Li N, Arnold DM, Down DG, Barty R, Blake J, Chiang F, Courtney T, Waito M, Trifunov R, Heddle NM | 2022 | Transfusion | View From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization | Researchers | New or improved product or process |
U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysis | Cannon JW, Igra NM, Borge PD, Cap AP, Devine D, Doughty H, Geng Z, Guzman JF, Ness PM, Jenkins DH, Rajbhandary S, Schmulevich D, Stubbs JR, Wiebe DJ, Yazer MH, Spinella PC | 2022 | Transfusion | View U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysis | Health care providers | Clinical research |
A flow cytometric method for platelet counting in platelet concentrates | van der Meer PF, Karssing-van Leeuwen W, Kurtz J, Spengler H-P, Blair A, Devine D, Harrison P, Lambrecht B, VandenBroeke T, de Wildt J, de Korte D, on behalf of the Biomedical Excellence for Safer Transfusion C | 2012 | Transfusion | View A flow cytometric method for platelet counting in platelet concentrates | Researchers | New or improved product or process |
Evaluation of CONSORT compliance in TRANSFUSION | Jaffer AM, Wang G, Barty RL, Shih AW | 2015 | Transfusion | View Evaluation of CONSORT compliance in TRANSFUSION | Researchers | Other |
Platelet transfusion reactions do not occur more often in recipients transfused with apheresis versus buffy coat platelet concentrates | Cserti-Gazdewich C, Escorcia A, Pendergrast J, Lieberman L, Skeate R, Lin Y, Callum J | 2016 | Transfusion | View Platelet transfusion reactions do not occur more often in recipients transfused with apheresis versus buffy coat platelet concentrates | Researchers | Clinical research |
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Bhagirath VC, Kelton JG, Moore J, Arnold DM | 2012 | Transfusion | View Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Health care providers | Clinical research |
Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw | Bhakta V, Jenkins C, Ramirez-Arcos S, Sheffield WP | 2014 | Transfusion | View Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw | Blood operators | New or improved product or process |
Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Goldman M, Uzicanin S, Yi QL, Acker JP, Ramirez-Arcos S | 2012 | Transfusion | View Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services | Blood operators | New or improved product or process |
Compliance with time-based deferrals for men who have sex with men | O'Brien SF, Osmond L, Fan W, Yi Q-L, Goldman M | 2019 | Transfusion | View Compliance with time-based deferrals for men who have sex with men | Researchers | MSM research |
Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study | Jackson Chornenki NL, James TE, Barty R, Liu Y, Rochwerg B, Heddle NM, Siegal DM | 2020 | Transfusion | View Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study | Health care providers | Clinical research |
COVID-19 convalescent plasma: Interim recommendations from the AABB | Cohn CS, Estcourt L, Grossman BJ, Pagano MB, Allen ES, Bloch EM, Casadevall A, Devine DV, Dunbar NM, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Beaudoin G, Tobian AAR | 2021 | Transfusion | View COVID-19 convalescent plasma: Interim recommendations from the AABB | Health care providers | Clinical research |
Evaluation of a pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) deferral policy among blood donors | Saeed S, Goldman M, Uzicanin S, O'Brien SF | 2021 | Transfusion | View Evaluation of a pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) deferral policy among blood donors | Blood operators | New or improved product or process |
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Leblanc J-F, Germain M, Delage G, O'Brien S, Drews SJ, Lewin A | 2020 | Transfusion | View Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Health care providers | Clinical research |
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Caffrey N, Goldman M, Osmond L, Yi Q-L, Fan W, O'Brien SF | 2022 | Transfusion | View HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Regulators | MSM research |
Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Balitsky A, Arnold D | 2022 | Transfusion | View Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Health care providers | Clinical research |
KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Ning S, Morin PA, Elahie A, Li N, Liu Y, Barty R, Clarke G, Zeller M, Heddle NM | 2023 | Transfusion | View KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study | Health care providers | Clinical research |
An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients | Lieberman L, Liu Y, Portwine C, Barty RL, Heddle NM | 2014 | Transfusion | View An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients | Health care providers | Clinical research |
Enhanced Pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations | Hodgson SD, Greco-Stewart V, Jimenez CS, Sifri CD, Brassinga AKC, Ramirez-Arcos S | 2014 | Transfusion | View Enhanced Pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations | Blood operators | Basic research |
Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus | Loza-Correa M, Kou Y, Taha M, Kalab M, Ronholm J, Schlievert PM, Cahill MP, Skeate R, Cserti-Gazdewich C, Ramirez-Arcos S | 2017 | Transfusion | View Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus | Health care providers | Clinical research |
Cold-stored leukoreduced whole blood: Extending the time between donation and filtration has minimal impact on in vitro quality | Schubert P, Chen Z, Bhakta V, Culibrk B, Wambolt R, Sheffield WP, Devine DV, McTaggart K | 2021 | Transfusion | View Cold-stored leukoreduced whole blood: Extending the time between donation and filtration has minimal impact on in vitro quality | Researchers | New or improved product or process |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |